ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 191 filers reported holding ASCENDIS PHARMA A/S in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,335,610 | +22.9% | 163,772 | +17.2% | 7.64% | +76.9% |
| Q2 2023 | $12,474,651 | -25.5% | 139,772 | -10.4% | 4.32% | -32.5% |
| Q1 2023 | $16,734,040 | +102123.8% | 156,072 | +16.4% | 6.39% | +20.8% |
| Q4 2022 | $16,370 | -99.9% | 134,036 | +8.6% | 5.29% | +26.3% |
| Q3 2022 | $12,742,000 | -14.1% | 123,400 | -22.6% | 4.19% | -18.3% |
| Q2 2022 | $14,827,000 | – | 159,500 | – | 5.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |